J.P. Morgan adjusts Kangji Medical derivative positions amid privatization scheme

On October 14, 2025, J.P. Morgan Securities PLC, an associate connected with the offeror and ultimately owned by JPMorgan Chase & Co., conducted two significant derivative transactions for its own account on October 13, 2025. This related to a privatization of Kangji Medical Holdings Limited by way of scheme of arrangement.

One transaction involved closing a derivative contract for 783 reference securities, maturing on December 29, 2025, at a reference price of $8.8605. This resulted in $6,937.7700 paid/received, leaving a balance of 10,770,860 units.

Additionally, J.P. Morgan Securities PLC issued a new derivative for 3,000 reference securities, maturing on September 24, 2027, at a reference price of $8.9148. This transaction amounted to $26,744.4000 paid/received, bringing the resultant balance to 10,773,860 units.